We strongly recommend that the Department of Health and partners improve the training of clinicians to ensure that they conduct improved clinical screening, including TB screening, to avoid same‐day initiation of patients with low CD4 count who may be at risk of IRIS. The gene discussed is CD4; the disease is tuberculosis.